Aquestive Therapeutics Inc

NASDAQ:AQST   3:59:33 PM EDT
1.74
+0.35 (+25.18%)
4:29:15 PM EDT: $1.83 +0.09 (+5.17%)
Other Pre-Announcement

Aquestive Therapeutics Inc - QTRLY Net Loss Per Share - Basic And Diluted $ 0.36

Published: 08/02/2022 21:20 GMT
Aquestive Therapeutics Inc (AQST) - Aquestive Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update.
Q2 Revenue $13.3 Million.
Updating Its Full-year 2022 Financial Outlook.
Expects FY 2022 Total Revenue in the Range of $46 Million to $49 Million.
Qtrly Net Loss per Share - Basic and Diluted $ 0.36.
Q2 Earnings per Share View $-0.36, Revenue View $10.6 Million -- Refinitiv Ibes Data (analyst estimates).